Company intelligence / Profile preview

Nuokangde Biological Technology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Nuokangde Pharmaceutical Technology is a biotechnology company based in China that specializes in the research and development of innovative peptide and small molecule drugs. The company focuses on metabolic diseases, particularly targeting the GLP-1, GIP, and Glucagon receptors for the treatment of diabetes and obesity. Nuokangde operates as both an internal drug developer and a contract research organization (CRO), providing technical services in medicinal chemistry and pharmacology. Their expertise lies in optimizing peptide stability and half-life to create next-generation metabolic therapies.

Therapeutic areas: EndocrinologyGastroenterology
Modalities: Small moleculePeptides
Industry: Biotech

Drug pipeline

1 asset

MsNK cells

Unknown

Beyond the preview

Go deeper on Nuokangde Biological Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuokangde Biological Technology.

Explore the full profile